These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 23582217)

  • 21. Hepatitis C virus infection in heart transplantation: is ventricular assist device therapy an option?
    Rajagopalan N; Hoopes CW; Rosenau J
    Transplantation; 2013 Aug; 96(4):e23-4. PubMed ID: 23958885
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C.
    Liu SS; Schneekloth TD; Talwalkar JA; Kim WR; Poterucha JJ; Charlton MR; Wiesner RH; Gross JB
    J Clin Gastroenterol; 2010 Sep; 44(8):e178-85. PubMed ID: 20495464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
    Magliocco MA; Gottlieb AB
    J Am Acad Dermatol; 2004 Oct; 51(4):580-4. PubMed ID: 15389194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.
    Dieterich DT; Wasserman R; Bräu N; Hassanein TI; Bini EJ; Bowers PJ; Sulkowski MS
    Am J Gastroenterol; 2003 Nov; 98(11):2491-9. PubMed ID: 14638354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of hepatitis C virus infection on methadone maintenance treatment.
    Novick DM
    Mt Sinai J Med; 2000; 67(5-6):437-43. PubMed ID: 11064495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selection of therapy in patients with chronic hepatitis C showing features like autoimmune hepatitis].
    Kakumu S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):663-6. PubMed ID: 15359881
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary hypertension and hepatitis C virus related cirrhosis.
    Perrone C; Paroli M; Morelli S
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):283-4. PubMed ID: 9646225
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.
    Rallón NI; Morello J; Labarga P; Benito JM; Rodríguez-Nóvoa S; Vispo E; Barreiro P; Castro MÁ; Aguirrebengoa K; Pineda JA; Miralles P; Tellez MJ; Portu J; Miralles C; Ocampo A; Soriano V;
    Clin Infect Dis; 2011 Dec; 53(12):1291-5. PubMed ID: 22028438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Course of liver fibrosis in HIV-hepatitis C virus-coinfected patients depending on the response to hepatitis C therapy.
    Cartón JA; Collazos J; de la Fuente B; Asensi V
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):215-22. PubMed ID: 22734850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of potential interactions between antiretroviral therapy and boceprevir or telaprevir in human immunodeficiency virus-hepatitis C virus coinfected patients].
    González-Colominas E; Solà R; Barrantes-González M; Salas E
    Enferm Infecc Microbiol Clin; 2013 May; 31(5):350-1. PubMed ID: 23182365
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C therapy and anticonvulsants.
    Bartres C; Soy G; Forns X
    Gastroenterol Hepatol; 2021; 44(7):536. PubMed ID: 33253770
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis C virus-infected patients with a history of epileptic fits can and should be treated with standard therapy].
    González-Mendez Y; Hernández-Guerra M; Turnes J; Abreu I; García D; Quintero E
    Gastroenterol Hepatol; 2013; 36(7):494-5. PubMed ID: 23582217
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
    Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies.
    Bhattacharya D; Imperial JC; Keeffe EB
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):288-92. PubMed ID: 16527689
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.